New York-based MSCI Inc. (MSCI) provides research-based data, analytics, and indexes, supported by advanced technology worldwide. The company has a market cap of $40 billion and provides indexes for use in various areas of the investment process, performance benchmarking, portfolio construction and rebalancing, asset allocation and related services.
MSCI is expected to release its Q1 2026 earnings soon. Ahead of the event, analysts expect the company’s EPS to be $4.38 on a diluted basis, up 9.5% from $4 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.
For fiscal 2026, analysts project the company’s EPS to be $19.44, up 12.5% from $17.28 in fiscal 2025. Moreover, its EPS is expected to rise by roughly 13.2% year over year (YoY) to $22 in fiscal 2027.
MSCI stock has declined 5.4% over the past 52 weeks, underperforming the S&P 500 Index’s ($SPX) 22% rise and the State Street Financial Select Sector SPDR ETF’s (XLF) 12.1% rise during the same time frame.
On Jan. 28, MSCI stock rose 5.7% following the release of its Q4 2025 earnings. The company’s revenue increased nearly 11% from the prior year’s quarter to $822.5 million. Moreover, its adjusted EPS also rose 11.5% from its year-ago value to $4.66. The company attributed this growth to higher asset-based fees and growth in recurring subscription revenue.
Analysts are moderately bullish on MSCI, with the stock having a “Moderate Buy” rating overall. Among the 20 analysts covering the stock, 13 are recommending a “Strong Buy,” two suggest a “Moderate Buy,” four suggest a “Hold,” and one suggests a “Strong Buy.” MSCI’s average analyst price target is $670.39, indicating an upside of 22.8% from the current levels.
On the date of publication, Aritra Gangopadhyay did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
